Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat Use of Picato for Anogenital Warts
NCT02377999Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Feb 2015
- Primary completion
- Nov 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ingenol mebutate in anogenital warts, sponsored by LEO Pharma. Primary endpoint: Number of incidence and severity of Local Skin Reactions (LSR). Started Feb 2015; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
anogenital warts
Beyond the preview
Go deeper on NCT02377999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02377999.